India’s Glenmark Life Sciences posts lower Q4 profit as Red Sea crisis hurts API business

Indian drugmaker Glenmark Life Sciences posted its first drop in profit for six quarters on Thursday as its mainstay active pharmaceutical ingredients (API) business was hurt by the Red Sea crisis.